Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2008 1
2011 1
2014 1
2015 1
2016 1
2017 1
2019 1
2020 1
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Disentangling oncogenic amplicons in esophageal adenocarcinoma.
Ng AWT, McClurg DP, Wesley B, Zamani SA, Black E, Miremadi A, Giger O, Hoopen RT, Devonshire G, Redmond AM, Grehan N, Jammula S, Blasko A, Li X, Aparicio S, Tavaré S; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium; Nowicki-Osuch K, Fitzgerald RC. Ng AWT, et al. Among authors: blasko a. Nat Commun. 2024 May 14;15(1):4074. doi: 10.1038/s41467-024-47619-4. Nat Commun. 2024. PMID: 38744814 Free PMC article.
[Hemostatic abnormalities in ischemic stroke].
Misz M, Oláh L, Kappelmayer J, Blaskó G, Udvardy M, Fekete I, Csépány T, Ajzner E, Csiba L. Misz M, et al. Among authors: blasko g. Orv Hetil. 1998 Oct 18;139(42):2503-7. Orv Hetil. 1998. PMID: 9810164 Review. Hungarian.
They conclude that in the acute phase of the disease, the TAT and F 1 + 2 values were significantly elevated compared to the control, without change in the D-dimer value. ...The results of the study were separately analyzed in acute, chronic TIA and stroke groups. In the T …
They conclude that in the acute phase of the disease, the TAT and F 1 + 2 values were significantly elevated compared to the control, …
European survey on national harmonization in clinical research.
Magnin A, Iversen VC, Calvo G, Čečetková B, Dale O, Demlová R, Blaskó G, Keane F, Kovacs GL, Levy-Marchal C, Monteiro EC, Palmisano L, Pella D, Portolés A, Rascol O, Schmid C, Tay F, von der Leyen H, Ohmann C. Magnin A, et al. Among authors: blasko g. Learn Health Syst. 2020 Feb 21;5(2):e10220. doi: 10.1002/lrh2.10220. eCollection 2021 Apr. Learn Health Syst. 2020. PMID: 33889730 Free PMC article.
Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity.
Katz-Summercorn AC, Jammula S, Frangou A, Peneva I, O'Donovan M, Tripathi M, Malhotra S, di Pietro M, Abbas S, Devonshire G, Januszewicz W, Blasko A, Nowicki-Osuch K, MacRae S, Northrop A, Redmond AM, Wedge DC, Fitzgerald RC. Katz-Summercorn AC, et al. Among authors: blasko a. Nat Commun. 2022 Mar 17;13(1):1407. doi: 10.1038/s41467-022-28237-4. Nat Commun. 2022. PMID: 35301290 Free PMC article.
The interaction of thrombomodulin with Ca2+.
Light DR, Glaser CB, Betts M, Blasko E, Campbell E, Clarke JH, McCaman M, McLean K, Nagashima M, Parkinson JF, Rumennik G, Young T, Morser J. Light DR, et al. Among authors: blasko e. Eur J Biochem. 1999 Jun;262(2):522-33. doi: 10.1046/j.1432-1327.1999.00398.x. Eur J Biochem. 1999. PMID: 10336638 Free article.
Thrombomodulin (TM) is a cofactor for protein C activation by thrombin and each residue of a consensus Ca2+ site in the sixth epidermal growth factor domain (EGF6) is essential for this cofactor activity [Nagashima, M., Lundh, E., Leonard, J.C., Morser, J. & Parkinson, J.F …
Thrombomodulin (TM) is a cofactor for protein C activation by thrombin and each residue of a consensus Ca2+ site in the sixth epidermal grow …
European survey on national training activities in clinical research.
Magnin A, Iversen VC, Calvo G, Čečetková B, Dale O, Demlova R, Blasko G, Keane F, Kovacs GL, Levy-Marchal C, Monteiro EC, Palmisano L, Pella D, Portolés Pérez A, Rascol O, Schmid C, Tay F, von der Leyen H, Ohmann C. Magnin A, et al. Among authors: blasko g. Trials. 2019 Oct 29;20(1):616. doi: 10.1186/s13063-019-3702-z. Trials. 2019. PMID: 31665085 Free PMC article.
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study.
Jones CM, O'Connor H, O'Donovan M, Hayward D, Blasko A, Harman R, Malhotra S, Debiram-Beecham I, Alias B, Bailey A, Bateman A, Crosby TDL, Falk S, Gollins S, Hawkins MA, Kadri S, Levy S, Radhakrishna G, Roy R, Sripadam R, Fitzgerald RC, Mukherjee S. Jones CM, et al. Among authors: blasko a. EClinicalMedicine. 2022 Sep 23;53:101664. doi: 10.1016/j.eclinm.2022.101664. eCollection 2022 Nov. EClinicalMedicine. 2022. PMID: 36187722 Free PMC article.
13 results